Safety & Clinical Performance Study of Catheter Ablation With the Centauri System for Patients With Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT04523545

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Galaxy Medical, Inc. (from the registry)
Registry
  • NCT NCT04523545
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Croatia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04523545. Allocation not applicable; no masking; primary purpose treatment. Start 2020-09-28 (actual); primary completion 2023-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety & Clinical Performance Study of Catheter Ablation With the Centauri System for Patients With Atrial Fibrillation
Acronym
ECLIPSE AF
Intervention (Device)
cardiac ablation
Lead sponsor
Galaxy Medical, Inc. (class: industry)

Record details

Record id
cardio:ct-nct04523545
Content hash
2e5c75852290cae529ebdbb2ed1bb349bfb756f959456a7835d3854e6134d9d4